LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 26 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,083,464 | -24.3% | 2,353,141 | 0.0% | 0.76% | -21.2% |
| Q2 2023 | $17,272,055 | +182944.2% | 2,353,141 | 0.0% | 0.97% | +55.9% |
| Q1 2023 | $9,436 | +36.6% | 2,353,141 | +11.1% | 0.62% | +34.4% |
| Q4 2022 | $6,906 | -99.9% | 2,118,283 | 0.0% | 0.46% | -16.2% |
| Q3 2022 | $7,880,000 | +12.2% | 2,118,283 | -6.8% | 0.55% | +3.8% |
| Q2 2022 | $7,024,000 | -42.1% | 2,273,221 | 0.0% | 0.53% | -43.0% |
| Q1 2022 | $12,139,000 | +9.7% | 2,273,221 | 0.0% | 0.93% | +41.6% |
| Q4 2021 | $11,069,000 | -45.1% | 2,273,221 | 0.0% | 0.66% | -19.7% |
| Q3 2021 | $20,155,000 | -3.4% | 2,273,221 | -2.1% | 0.82% | +15.5% |
| Q2 2021 | $20,869,000 | -43.9% | 2,321,403 | -1.5% | 0.71% | -14.5% |
| Q1 2021 | $37,193,000 | – | 2,356,000 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,353,141 | $13,083,464 | 0.76% |
| Integral Health Asset Management, LLC | 760,000 | $4,225,600 | 0.58% |
| Prosight Management, LP | 321,154 | $1,785,616 | 0.57% |
| Parkman Healthcare Partners LLC | 355,957 | $1,979,121 | 0.36% |
| Ikarian Capital, LLC | 514,101 | $2,858,401 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,560,500 | $8,676,380 | 0.04% |
| Polar Capital Holdings Plc | 1,000,000 | $5,560,000 | 0.04% |
| UBS OCONNOR LLC | 262,265 | $1,458,193 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 112,614 | $626,134 | 0.02% |
| Point72 Asset Management, L.P. | 825,000 | $4,587,000 | 0.01% |